No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
REGN241220C770000
- 1.50
- -2.70-64.29%
15min DelayClose Dec 13 16:00 ET
1.90High1.50Low
1.90Open4.20Pre Close3 Volume58 Open Interest770.00Strike Price530.00Turnover44.53%IV5.50%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry1.50Extrinsic Value100Contract SizeAmericanOptions Type0.1589Delta0.0066Gamma245.82Leverage Ratio-0.9689Theta0.0142Rho39.06Eff Leverage0.1982Vega
Intraday
- 5D
- Daily
News
BofA Restarts Coverage of 11 Large-cap Biopharmas
Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Maintains Target Price $1,195
Regeneron Pharmaceuticals (REGN): Sales Struggles and Future Prospects
B of A Securities Reinstates Underperform on Regeneron Pharmaceuticals, Announces $565 Price Target
Regeneron Pharmaceuticals Analyst Ratings
Regeneron Presents New And Updated Data For Odronextamab At ASH Annual Meeting